About Gene List

PF3D7_0208000 (SERA1)

Genome location: Pf3D7_02_v3:322,329..326,390(-)

Genome classification: Core

Function and Localization

Product Description: serine repeat antigen 1

SignalP Peptide: MKFFIPYVYIICVIFIINVIRTRG

# Transmembrane Domains: 0

EC Numbers: 3.4.22.- (Cysteine endopeptidases.)

Curated GO (PlasmoDB):

Type GO Term Name
Component GO:0005615 extracellular space
Component GO:0005764 lysosome
Function GO:0004197 cysteine-type endopeptidase activity
Function GO:0008234 cysteine-type peptidase activity
Process GO:0002377 immunoglobulin production
Process GO:0006508 proteolysis
Process GO:0051603 proteolysis involved in cellular protein catabolic process
Process GO:0050776 regulation of immune response

Expression by stage (LR - Le Roch et al., and MCA - Malaria Cell Atlas):

Stage LR class MCA mean MCA prop. zeros
Sporozoite not expressed N/A N/A
Ring not expressed 0.03 0.99
Trophozoite not expressed 0.19 0.89
Schizont possibly expressed 0.76 0.60
Gametocyte not expressed 0.32 0.82

More info:

Resistome Mutations

Old (Pf3D7v3) Gene ID: PF3D7_0208000

Resistome Missense Mutations: N184D

Resistome Compounds with Missense Mutations: BRD73842

Resistome # Samples with Disruptive Mutations: 1 (1 missense, 0 "interesting" missense)

Essentiality (ABS)

Zhang Phenotype: Mutable in CDS

MIS: 0.98 | MFS: -2.772 | #Insertions: 1

PlasmoGEM Phenotype: Dispensable (Pb ortholog: PBANKA_0305100)

  • Relative Growth Rate: 1.04 ± 0.17
  • Confidence: 4.93

RMgmDB ABS Phenotype: N/A

More info: PhenoPlasm Link

Binding Evidence

AlphaFill Uniprot ID: O96167

"Best" AlphaFill ligand hit: E64 (n-[n-[1-hydroxycarboxyethyl-carbonyl]leucylamino-butyl]-guanidine, Local RMSD=0.32) with 3H7D (Global RMSD=9.99)

BRENDA EC Inhibitors:

EC # Name EC Inhibitors
3.4.22.- Ex: staphylococcal cysteine proteinase NEME64SpiSDSCysEDTAPCMBEGTAPMSFTLCKTPCKMENT...

No evidence of orthology to BindingDB entries

Orthology Information

Ortholog Group (OrthoMCL): OG6_126098

No human ortholog(s)

Genetic Variation

MalariaGEN Pf7 (worldwide samples) # unique SNV/indels:

Homozygous genotype calls only

variant type common rare doubleton singleton
synonymous 12 43 31 60
disruptive 17 100 68 153
missense 17 97 64 148

Any inclusion in genotype call

variant type common rare doubleton singleton
synonymous 20 90 37 63
disruptive 44 196 107 257
missense 38 181 94 212

PlasmoDB Total SNPs: 177

Non-coding: 103 | Synonymous: 48 | Nonsynonymous: 26 | Stop Codon: 0

Protein Information

Protein Length: 994 | Molecular Weight (kDa): 115.496

UniProt ID(s): A0A0E3VL28, A0A0E4B1T9, A0A0E4B265, A0A0E4B3I5, A0A0E4FHY6, A0A0E4FJA4, I0IYU3, I0IYU9, I0IYV8, I0IYZ9, O96167

PDB ID(s): None

Isoelectric Point: 8.06

Protein Domain Annotations:

Source Family ID Description
InterPro IPR000668 Peptidase C1A, papain C-terminal
InterPro IPR025661 Cysteine peptidase, asparagine active site
InterPro IPR038765 Papain-like cysteine peptidase superfamily
PFam PF00112 Peptidase C1A, papain C-terminal
Superfamily SSF54001 Papain-like cysteine peptidase superfamily

Associated Publications

PMID Title Authors DOI/Link
9804551 Chromosome 2 sequence of the human malaria parasite Plasmodium falciparum. Gardner MJ, Tettelin H, ..., Hoffman SL 10.1126/science.282.5391.1126
12228245 A subset of Plasmodium falciparum SERA genes are expressed and appear to play animportant role in the erythrocytic cycle. Miller SK, Good RT, ..., Crabb BS 10.1074/jbc.M206974200
12368864 Genome sequence of the human malaria parasite Plasmodium falciparum. Gardner MJ, Hall N, ..., Barrell B 10.1038/nature01097
17609844 Phylogeny and evolution of the SERA multigene family in the genus Plasmodium Arisue N, Hirai M, ..., Horii T 10.1007/s00239-006-0253-1
31052291 Targeting the Serine Pathway: A Promising Approach against Tuberculosis Haufroid M, Wouters J 10.3390/ph12020066
29684399 A Cas9 transgenic Plasmodium yoelii parasite for efficient gene editing Qian P, Wang X, ..., Yuan J 10.1016/j.molbiopara.2018.04.003
17893128 Evidence for a common role for the serine-type Plasmodium falciparum serinerepeat antigen proteases: implications for vaccine and drug design McCoubrie JE, Miller SK, ..., Crabb BS 10.1128/IAI.00405-07
14963770 Transcription status of vaccine candidate genes of Plasmodium falciparum duringthe hepatic phase of its life cycle Bodescot M, Silvie O, ..., Mazier D 10.1007/s00436-003-1061-9